Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of Cell-derived H1N1 Influenza Vaccine in Children and Adolescents
NCT00971100Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2009
- Primary completion
- Mar 2010
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 3
01
Overview
A Phase 3 trial of Influenza A (H1N1) vaccine in influenza A/H1N1 (H1N1), sponsored by Novartis. Started Aug 2009; status: completed.
02
Drugs
Influenza A (H1N1) vaccine
03
Conditions
influenza A/H1N1 (H1N1)
Beyond the preview
Go deeper on NCT00971100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00971100.